| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 654658 | 57204 | DOLOTREN 75 mg SOLUCION INYECTABLE | DOLOTREN 75 mg SOLUCION INYECTABLE , 6 ampollas de 3 ml | 75 mg | 1 | 6 | 1 | 6 ampollas de 3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57204/57204_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57204/57204_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41329 | FAES FARMA S.A. | 1987-10-01 | 1 | 1 | 1 | 1987-10-01 | 2013-02-07 | 1 | 2014-01-02 | 972042 | View Edit Delete | |||||||||||
| 652778 | 59352 | IGANTIBE 200 UI/ml SOLUCION INYECTABLE | IGANTIBE 200 UI/ml SOLUCION INYECTABLE , 1 ampolla de 3 ml | 600 UI | 1 | 1 | 1 | 1 ampolla de 3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59352/59352_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59352/59352_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3896 | INSTITUTO GRIFOLS S.A. | 1992-02-01 | 1 | 1 | 1 | 1992-02-01 | 2011-10-27 | 1 | 2011-11-22 | 709238 | View Edit Delete | |||||||||||
| 652656 | 67213 | PRIOSOL CON 4 mmol/L DE POTASIO SOLUCION PARA HEMOFILTRACION | PRIOSOL CON 4 mmol/L DE POTASIO SOLUCION PARA HEMOFILTRACION , 2 bolsas de 5.000 ml | N/A (más de 4 PA) | 3 | 2 | 65 | 2 bolsas de 5.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67213/67213_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67213/67213_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9126 | B BRAUN MEDICAL S.A. | 2005-11-15 | 1 | 1 | 1 | 2005-11-15 | 2005-11-15 | 0 | 2012-01-09 | View Edit Delete | ||||||||||||
| 652658 | 67214 | PRIOSOL CON 2 mmol/L DE POTASIO SOLUCION PARA HEMOFILTRACION | PRIOSOL CON 2 mmol/L DE POTASIO SOLUCION PARA HEMOFILTRACION , 2 bolsas de 5.000 ml | N/A (más de 4 PA) | 3 | 2 | 65 | 2 bolsas de 5.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67214/67214_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67214/67214_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9126 | B BRAUN MEDICAL S.A. | 2005-11-15 | 1 | 1 | 1 | 2005-11-15 | 2005-11-15 | 0 | 2012-01-09 | View Edit Delete | ||||||||||||
| 652659 | 67215 | PRIOSOL SIN POTASIO SOLUCION PARA HEMOFILTRACION | PRIOSOL SIN POTASIO SOLUCION PARA HEMOFILTRACION , 2 bolsas de 5.000 ml | N/A (más de 4 PA) | 3 | 2 | 65 | 2 bolsas de 5.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67215/67215_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67215/67215_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9126 | B BRAUN MEDICAL S.A. | 2005-11-15 | 1 | 1 | 1 | 2005-11-15 | 2005-11-15 | 0 | 2012-01-09 | View Edit Delete | ||||||||||||
| 653975 | 67610 | ACCUSOL 35 SOLUCION PARA HEMOFILTRACION, HEMODIALISIS Y HEMODIAFILTRACION | ACCUSOL 35 SOLUCION PARA HEMOFILTRACION, HEMODIALISIS Y HEMODIAFILTRACION , 2 bolsas de 5.000 ml | 0,343 mg/ml + 0,136 mg/ml + 7,52 mg/ml + 13,4 mg/ml inyectable 5.000 ml | 3 | 2 | 65 | 2 bolsas de 5.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67610/67610_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67610/67610_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17503 | PALEX MEDICAL S.A. | 2006-03-16 | 1 | 1 | 1 | 2006-03-16 | 2006-03-16 | 1 | 2012-04-18 | View Edit Delete | ||||||||||||
| 653976 | 67611 | ACCUSOL 35 POTASIO 2 mmol/L SOLUCION PARA HEMOFILTRACION, HEMODIALISIS Y HEMODIAFILTRACION | ACCUSOL 35 POTASIO 2 mmol/L SOLUCION PARA HEMOFILTRACION, HEMODIALISIS Y HEMODIAFILTRACION , 2 bolsas de 5.000 ml | N/A (más de 4 PA) | 3 | 2 | 65 | 2 bolsas de 5.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67611/67611_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67611/67611_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17503 | PALEX MEDICAL S.A. | 2006-03-16 | 1 | 1 | 1 | 2006-03-16 | 2006-03-16 | 1 | 2012-04-18 | View Edit Delete | ||||||||||||
| 653977 | 67612 | ACCUSOL 35 POTASIO 4 mmol/L SOLUCION PARA HEMOFILTRACION, HEMODIALISIS Y HEMODIAFILTRACION | ACCUSOL 35 POTASIO 4 mmol/L SOLUCION PARA HEMOFILTRACION, HEMODIALISIS Y HEMODIAFILTRACION , 2 bolsas de 5.000 ml | N/A (más de 4 PA) | 3 | 2 | 65 | 2 bolsas de 5.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67612/67612_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67612/67612_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17503 | PALEX MEDICAL S.A. | 2006-03-16 | 1 | 1 | 1 | 2006-03-16 | 2006-03-16 | 1 | 2019-06-12 | View Edit Delete | ||||||||||||
| 653570 | 67459 | VIAFLO CLORURO SODICO 0,9% Y CLORURO POTASICO 0,15%, SOLUCION PARA PERFUSION | VIAFLO CLORURO SODICO 0,9% Y CLORURO POTASICO 0,15%, SOLUCION PARA PERFUSION, 20 bolsas de 500 ml | 0,9% + 10 mEq/500 ml | 3 | 20 | 65 | 20 bolsas de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67459/67459_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67459/67459_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 2006-01-18 | 1 | 1 | 1 | 2006-01-18 | 2006-01-18 | 0 | 2011-06-24 | View Edit Delete | ||||||||||||
| 654436 | 67821 | VIAFLO PLASMALYTE 148 (PH 7,4), SOLUCION PARA PERFUSION | VIAFLO PLASMALYTE 148 (PH 7,4), SOLUCION PARA PERFUSION, 20 bolsas de 500 ml | N/A (más de 4 PA) | 3 | 20 | 65 | 20 bolsas de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67821/67821_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67821/67821_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 2006-05-22 | 1 | 1 | 1 | 2006-05-22 | 2006-05-22 | 1 | 2011-06-24 | View Edit Delete | ||||||||||||
| 653906 | 67589 | EBASTINA ALTER 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EBASTINA ALTER 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 10 mg | 4 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67589/67589_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67589/67589_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | LABORATORIOS ALTER S.A. | 2006-03-01 | 1 | 1 | 1 | 2006-03-01 | 2006-03-01 | 1 | 2011-11-11 | View Edit Delete | ||||||||||||
| 654045 | 67647 | AMISULPRIDA TARBIS 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMISULPRIDA TARBIS 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 400 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67647/67647_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67647/67647_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2006-03-28 | 1 | 1 | 1 | 2006-03-28 | 2006-03-28 | 1 | 2020-10-29 | View Edit Delete | ||||||||||||
| 654109 | 67663 | EBASTINA TARBIS 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EBASTINA TARBIS 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 10 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67663/67663_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67663/67663_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2006-03-29 | 1 | 1 | 1 | 2006-03-29 | 2006-03-29 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 654110 | 67664 | EBASTINA TARBIS 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EBASTINA TARBIS 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 20 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67664/67664_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67664/67664_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2006-03-29 | 1 | 1 | 1 | 2006-03-29 | 2006-03-29 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 653920 | 66291 | ENALAPRIL/HIDROCLOROTIAZIDA ABABOR 20 mg/12,5 mg comprimidos EFG | ENALAPRIL/HIDROCLOROTIAZIDA ABABOR 20 mg/12,5 mg comprimidos EFG , 28 comprimidos | 20 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66291/66291_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66291/66291_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15730 | ABABOR PHARMACEUTICALS S.L. | 2004-08-25 | 1 | 1 | 1 | 2004-08-25 | 2012-04-19 | 1 | 2013-01-03 | 837070, 653380, 656782, 656931 | View Edit Delete | |||||||||||
| 653957 | 69762 | LOSARTAN / HIDROCLOROTIAZIDA ABABOR 100/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LOSARTAN / HIDROCLOROTIAZIDA ABABOR 100/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 100 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69762/69762_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69762/69762_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15730 | ABABOR PHARMACEUTICALS S.L. | 2008-04-21 | 1 | 1 | 1 | 2008-04-21 | 2012-04-19 | 1 | 2017-06-07 | 660887, 652983 | View Edit Delete | |||||||||||
| 653965 | 69761 | LOSARTAN / HIDROCLOROTIAZIDA ABABOR 50/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LOSARTAN / HIDROCLOROTIAZIDA ABABOR 50/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 50 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69761/69761_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69761/69761_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15730 | ABABOR PHARMACEUTICALS S.L. | 2008-04-21 | 1 | 1 | 1 | 2008-04-21 | 2012-04-19 | 1 | 2017-06-07 | 660885, 663342, 652975 | View Edit Delete | |||||||||||
| 653809 | 60319 | SANDIMMUN NEORAL 25 mg CAPSULAS BLANDAS | SANDIMMUN NEORAL 25 mg CAPSULAS BLANDAS, 30 cápsulas | 25 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60319/60319_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60319/60319_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1994-11-01 | 1 | 1 | 1 | 1994-11-01 | 2012-03-27 | 1 | 2013-01-03 | 650092, 692368, 662163 | View Edit Delete | |||||||||||
| 653817 | 60318 | SANDIMMUN NEORAL 50 mg CAPSULAS BLANDAS | SANDIMMUN NEORAL 50 mg CAPSULAS BLANDAS, 30 cápsulas | 50 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60318/60318_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60318/60318_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1994-11-01 | 1 | 1 | 1 | 1994-11-01 | 2012-03-27 | 1 | 2013-01-03 | 662171, 692376, 650093 | View Edit Delete | |||||||||||
| 653825 | 60320 | SANDIMMUN NEORAL 100 mg CAPSULAS BLANDAS | SANDIMMUN NEORAL 100 mg CAPSULAS BLANDAS , 30 cápsulas | 100 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60320/60320_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60320/60320_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1994-11-01 | 1 | 1 | 1 | 1994-11-01 | 2012-03-27 | 1 | 2013-01-03 | 662189, 650094, 692350 | View Edit Delete |
Page 90 of 1036, showing 20 records out of 20709 total, starting on record 1781, ending on 1800